Skip to main content
Fig. 3 | Clinical Proteomics

Fig. 3

From: Proteomic profiling of end-stage COVID-19 lung biopsies

Fig. 3

Histopathology of COVID-19 patient lung tissue reveals loss of extracellular matrix and prominent infiltration of immune cells. A Movat pentachrome stain of lung tissue slices from COVID-19 patients. ae 20 × images, b 10 × overview. Whilst overall tissue structure is still well defined, none stained positive for collagen and reticular fibres. B a 10 × overview, bf 20 × images of healthy lung tissue controls. Except f all of the healthy controls display a strong positive staining result (brownish yellow) for collagen and reticular fibres. The reduced signal in f could be explained by an incidental focal inflammation. C af 20 × images of H&E stains of COVID-19 samples. Samples display a varying amount of infiltrated immune cells, from minor, early onset inflammation (a, b, f) to advanced inflammation (d, e) to alveoli filled with infiltrate (c). D af 20 × images H&E stains of healthy control patients display clinically unremarkable lung parenchyma. Displayed images are representatives of 10 pictures taken per each of the six COVID-19 and control patient analysed in this study

Back to article page